The complement component C4 variants C4A4, C4B 4 and C4B Q0 were found to be significantly increased in 64black patients with Type 1 (insulin-dependent) diabetes compared with 169 black control subjects, yielding relative risks of 3.3, 2.9 and 3.4, respectively. The increased frequencies of C4B 4 and C4B Q0 in black Type 1 diabetic patients are similar to those found in Caucasoid Type 1 diabetic patients. The data suggest that Type 1 diabetes in black Americans may be partially due to admixture of genes from whites.
Type 1 (insulin-dependent) diabetes mellitus has been shown to be associated with HLA, factor B (BI) and complement component C4 in various white populations [7, 9, 11, 13, 20, 23] . With the exception of C4 similar findings have been reported for black Americans with Type i diabetes [5, 17, 19, 25] .
The complement component C4 is determined by genes at two tightly-linked loci, C4A and C4B [1] which are closely linked to Bf and C2 [14] on chromosome 6 and probably lie between the HLA-B and -D/DR loci [4] . Studies of white subjects from the United States [1] have identified seven C4A variants and at least three C4B variants. Furthermore, data suggest that C4 is as polymorphic in the black population as in Caucasoids [61.
While recent studies have shown that C4B4 and C4B 2 are significantly increased in Type 1 diabetes in whites [3, 18] and that C4B Q0 is increased in Type 1 diabetes in the Basques [8] , at present no information is available on C4 phenotypes in black Type 1 diabetic patients. Studies by Reitnauer et al. [16] and Budowle et al. [5] suggest that the occurrence of Type 1 diabetes in black Americans may be partially due to admixture of genes from whites. Therefore, analysis of the C4 system is of interest, since it may offer additional support to the admixture hypothesis as well as identify an additional susceptibility marker for Type 1 diabetes in the black population. The purpose of this investigation was to determine whether or not there is an association of C4 with Type 1 diabetes in black patients from the southeastern United States.
Materials and methods
Plasma samples from 64 unrelated black Type I diabetic patients from the southeastern United States were phenotyped for C4 according to the method of Awdeh and Alper [1] and Awdeh et al. [2] . All patients were under age 40 years at onset of diabetes, insulin-dependent and ketosis-prone. The control sample, previously phenotyped for C4 [6] , included unrelated normal black individuals from the same geographical region without a personal or family history of diabetes and with normal fasting blood glucose levels. The relative risks were estimated using Woolf's odds ratio method [24] . The comparisons of C4 phenotypes between black patients and control subjects were made by use of the Z 2 statistic, with Yates' correction where appropriate. A probability level of 0.05 or less was considered significant.
Results
Twenty-eight different C4 phenotypes were observed in the sample of black Type 1 diabetic patients ( Table 1) . The percentage phenotypic frequencies of the C4A and C4B antigens in patients and controls are shown in Table 2 . The C4A 4 frequency is significantly increased in the patients (17.2% versus 5.9%; p = 0.007) for a relative risk of 3.3. C4B 4 is also significantly increased (14.1% versus 5.3%; p = 0.026) in this patient population for a relative risk of 2.9. In addition, the significant increase of C4B Q0 (9.4% versus 3.0%; p= 0.039) results in a relative risk of 3.4.
Discussion
This is the first report of an association of C4 with Type 1 diabetes in black Americans. The genetic associations of C4B 4 with Type 1 diabetes found in whites [3, 18] and C4B Q0 in the Basques [8] also occur in blacks. Furthermore, if confirmed the C4A 4 phenotype may be a unique association with Type 1 diabetes in blacks, although here the association is not significant after correction for the number of comparisons made. Interestingly, of the six patients positive for C4B Q0, five carried the Bf F1 allele [5] which supports linkage of C4B Q0 and Bf F1 as described in the Basque population [8] . This possibility cannot be confirmed at present because of sample size.
Since C4 is intimately involved with the immune response and host defence mechanisms [10, 15, 18, 23] it has been suggested that it may be causally related to Type 1 diabetes. Supporting this is the occurrence of the non-functional variant C4A6 [22] , and the high frequency of C4 null phenotypes in the population [1, 6] . It is possible that some C4 products may be more or less functional than others and might, therefore, be directly involved in the aetiology of Type I diabetes.
Obviously, all patients do not carry C4A4, C4B 4 and/or C4B Q0, while a portion of healthy controls do possess these risk factors. However, our understanding of the genetics of Type 1 diabetes suggests that the aetiology of this disease is the result of at least two genes. Thus, C4 may be part of an array of closely linked genes within the major histocompatibility complex which are functionally interrelated and may operate as a single gene. Included in this array may be the genes for Bf, C2 and HLA as well as others yet unidentified, leading to the possibility that a combination of altered gene products may be necessary for the development of Type 1 diabetes. However, there is as yet no evidence that C4A 4, C4B 4 and C4B Q0 are directly involved in the aetiology of Type 1 diabetes.
Studies suggest that there is a decreased incidence of Type 1 diabetes in the black American population compared with white Americans [12] . In addition, Type 1 diabetes has been shown to be rare in black Africans [21] . Reitnauer et al. [16] observed that there was a greater degree of racial admixture in the same black patient sample used in this study than seen in healthy black controls. This report adds further support to the racial admixture hypothesis since we found that the genetic association of C4B 4 with Type 1 diabetes is similar in both races, as already reported for HLA [17, 19, 25] and Bf [5] .
